Inventor profile of:

Siler Panowski

City:

Berkeley, California

Country:

United States

Published Applications:

23

Last publication date:

2026-05-28

Top Assignees for applications by Siler Panowski

The entities that hold a legal rights for patent applications filed by inventor Panowski Siler:

Recent patent applications by Panowski Siler

Siler Panowski from Berkeley, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-28
US20260146098A1
Chemistry; metallurgy

SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE

#2 | 2026-04-30
US20260116989A1
Chemistry; metallurgy

SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE

#3 | 2026-04-23
US20260109771A1
Chemistry; metallurgy

SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE

#4 | 2026-02-12
US20260042857A1
Chemistry; metallurgy

SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE

#5 | 2025-05-08
US20250145725A1
Chemistry; metallurgy

CHIMERIC ANTIGEN RECEPTORS TARGETING CD70

#6 | 2025-02-13
US20250051421A1
Chemistry; metallurgy

CONSTITUTIVELY ACTIVE CHIMERIC CYTOKINE RECEPTORS

#7 | 2025-01-09
US20250011446A1
Chemistry; metallurgy

ANTIBODIES SPECIFIC FOR CD70 AND THEIR USES

#8 | 2024-07-11
US20240228639A1
Chemistry; metallurgy

CD70 ANTI-IDIOTYPE ANTIBODIES

#9 | 2024-07-04
US20240216430A1
Human necessities

CLAUDIN 18.2 TARGETING CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENTS AND USES THEREOF

#10 | 2024-01-18
US20240016846A1
Human necessities

CHIMERIC CYTOKINE RECEPTORS BEARING A PD-1 ECTODOMAIN

#11 | 2023-11-02
US20230346934A1
Human necessities

CHIMERIC SWITCH RECEPTORS FOR THE CONVERSION OF IMMUNESUPPRESSIVE SIGNALS TO COSTIMULATORY SIGNALS

#12 | 2023-09-14
US20230287120A1
Chemistry; metallurgy

DLL3 TARGETING CHIMERIC ANTIGEN RECEPTORS AND BINDING AGENTS

#13 | 2023-02-09
US20230041456A1
Chemistry; metallurgy

Chimeric antigen receptors targeting CD70

#14 | 2023-01-05
US20230002498A1
Chemistry; metallurgy

Antibodies specific for CD70 and their uses

#15 | 2022-12-29
US20220409665A1
Human necessities

SELECTIVE TARGETING OF HOST CD70+ ALLOREACTIVE CELLS TO PROLONG ALLOGENEIC CAR T CELL PERSISTENCE

#16 | 2022-07-21
US20220227832A1
Chemistry; metallurgy

PROTEASE-ACTIVATING CD45-GATE CAR

#17 | 2021-08-26
US20210260118A1
Human necessities

BCMA CAR-T cells with enhanced activities

#18 | 2021-04-15
US20210107979A1
Chemistry; metallurgy

DLL3 targeting chimeric antigen receptors and binding agents

#19 | 2021-03-04
US20210061881A1
Chemistry; metallurgy

CHIMERIC CYTOKINE RECEPTORS COMPRISING TGF BETA BINDING DOMAINS

#20 | 2020-09-17
US20200291090A1
Chemistry; metallurgy

Constitutively active chimeric cytokine receptors

#21 | 2020-09-03
US20200276238A1
Human necessities

Chimeric cytokine receptors bearing a PD-1 ectodomain

#22 | 2019-08-01
US20190233529A1
Chemistry; metallurgy

Antibodies specific for CD70 and their uses

#23 | 2019-08-01
US20190233528A1
Chemistry; metallurgy

Chimeric antigen receptors targeting CD70

InventorID:

2573209 ⎘